| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |